Cancer treatment

Cancer treatment

Advances in Cancer Research: Combination Therapies Show Promise in Pancreatic Cancer Treatment

Recently published studies from the United States and Czech Republic have reported significant advances in the treatment of pancreatic cancer, with combination therapies demonstrating greater efficacy than single-agent treatments. Researchers have identified the potential of combining traditional chemotherapy with gene therapy, specifically oncolytic herpes viral gene therapy, and interleukin 12

Cancer treatment

Bevacizumab and Flavopiridol Show Promise in Cancer Treatment

Cancer research in the United States has yielded promising results with the use of bevacizumab and flavopiridol in treating various forms of cancer. Bevacizumab, an anti-angiogenic drug, has been shown to inhibit tumor growth and reduce angiogenesis in breast cancer patients. Flavopiridol, a cyclin-dependent kinase inhibitor, has demonstrated antiangiogenic properties

Cancer treatment

MedImmune Sponsors Cancer Research Fellowship to Support Development of Biologics-Based Cancer Therapies

MedImmune, Inc., a global biotechnology company, has sponsored an American Association for Cancer Research (AACR) fellowship to support the development of biologics-based cancer therapies. The recipient of the $40,000 research fellowship, Robert R. Jenq, MD, of the Memorial Sloan-Kettering Cancer Center in New York, is evaluating several techniques to

Cancer treatment

European Commission Approves Erbitux for Head and Neck Cancer Treatment

The European Commission has granted marketing authorization to extend the use of Erbitux (Cetuximab) in combination with radiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck. This development marks a significant advancement for patients with head and neck cancer, with Erbitux being the first and

Cancer treatment

Functional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines

A team of German researchers from the Deutsch Krebsforschungszentrum (German Cancer Research Center) has made a significant breakthrough in the field of cancer therapy. The study, published in Cancer Research, has revealed that cancer cell DNA methyltransferase inhibitors display functional diversity. This discovery has the potential to revolutionize cancer treatment,

Cancer treatment

Economic Evaluation of Herceptin in Adjuvant Breast Cancer Therapy

A recent study from the University of Ghent in Belgium provides essential information for policymakers considering reimbursement for Herceptin in breast cancer therapy. The study conducted a cost-effectiveness analysis of Herceptin, a humanized monoclonal antibody, in the adjuvant setting for breast cancer. Researchers calculated treatment costs and life expectancy data

Cancer treatment

Bioniche Life Sciences Receives Regulatory Approval for Bladder Cancer Program and Advances E. coli O157:H7 Cattle Vaccine

Bioniche Life Sciences Inc. has secured Canadian regulatory approval for its phase 3 bladder cancer program in Canada, while its E. coli O157:H7 cattle vaccine is proceeding through the U.S. regulatory pathway. The approval marks a significant milestone for the company, which aims to develop novel treatments for

Cancer treatment

Estrogen-Alone Therapy May Decrease Incidence of Breast Cancer for Some Women

Recent data from the Women's Health Initiative (WHI) study, published in the April 12, 2006 issue of the Journal of the American Medical Association (JAMA), suggest that estrogen-alone therapy may not increase breast cancer incidence in postmenopausal women and may even have a protective effect against breast cancer

Cancer treatment

Breakthrough in Cancer Research: Antibody Shows Promise in Preventing Tumor Growth

San Diego State University researcher Roger Sabbadini and his team have made a significant contribution to cancer research with the development of an antibody called Sphingomab. This antibody, which has been shown to inhibit the growth of tumors in experimental animal models, works by preventing blood vessel formation, a process

Cancer treatment

Hormone Therapy Linked to Increased Breast Cancer Risk in Black Women

Breast cancer risk increased significantly among black women taking combination hormone pills or estrogen tablets alone, while the risk of potentially lethal blood clots rose in all women on estrogen-only pills, according to separate studies. The largest study of its kind, conducted by Lynn Rosenberg of Boston University, found a

Cancer treatment

ImClone Systems Presents Pre-Clinical Data Highlighting Antibody Research Progress

ImClone Systems Incorporated has made significant progress in the development of its pre-clinical and clinical-stage antibody research programs. At the 97th Annual Meeting of the American Association for Cancer Research (AACR) in Washington, D.C., the company presented data from its developed antibodies, which target various signaling pathways linked to

Cancer treatment

Cancer Vaccines: A Comprehensive Review of Therapeutic Strategies and Immunological Mechanisms

Cancer vaccines hold promise for inducing effective antitumor immune responses in patients with cancer. However, the design of cancer vaccines must consider the stage of tumor growth and the states of tumor-specific CD8+ T cells. Researchers have identified critical immunological mechanisms underlying the efficacy and failure of therapeutic vaccinations. A